Health care
Healthcare sector - Sprouting green shoots of recovery
Fri, 05-Jan-2024 10:40 am
by Kenneth Leong • Apex Research

Review

After a downbeat performance in 1H23, sentiment over the healthcare sector turns more favourable, particularly within the gloves sector which continues to narrow their losses as well as chalking in marginal profit under the financial period under review. The said improvement was largely attributable to the cost rationalisation measures undertaken in bid to streamline operations efficiency as well as signs of stability in average selling prices (ASP). Demand is also on the mend with inventories tapered with purchasers reignited minor stockpiling activities. Meanwhile, we gather that natural rubber concentrated latex price has turned fairly stable at close to US$1.20/kg towards end-2023.

Elsewhere, healthcare services and equipment players will be reinforced by the higher budget allocation under Budget 2024 which saw 13.5% yoy rise in allocation to RM41.2bn. Healthcare-related projects such as development and upgrade of hospital facilities as well as equipment aligns with the Malaysia government goal to gradually uplift public health expenditure to 5.0% of gross domestic product (GDP) bodes well. All in, Bursa Malaysia’s healthcare sector added 9.7% yoy in 2023 to close at 1,903.93 pts


Outlook 

We expect ASP for rubber gloves to remain fairly stable at approximately US$20-22/1,000 pieces in 1H2024 as pricing gap with peers from regional players narrows. Still, margins are expected to remain lukewarm as any upward in price adjustment may be met with potentially weaker demand, while the upward revision of natural gas prices are limiting margins improvement. For now, we reckon local gloves players will continue to focus onto on-going capacity rationalisation measures, while banking onto inventory replenishment from prospective purchasers. While, utilisation rate is expected to see mild uptick, moving in 1H2024, we reckon the aforementioned figure will remain a distance from pre-Covid-19 pandemic levels.

On the other hand, we note that medical tourists are returning to Malaysia towards pre-pandemic levels, supported by reopening of borders, visa free travel for Chinese nationals, improved quality healthcare and competitive pricing. Back home, the ageing population, rising healthcare awareness and improving healthcare technology will be some of the key avenue drivers for the healthcare industry.


Valuation & Recommendation 

While outlook for gloves players is turning brighter, we reckon that recent recovery in their share prices has reflected the prospects of improved fundamentals. While we do not have any top picks for the sector, we hold a favourable view of Hartalega (SELL, TP: RM2.09) due to its substantial net cash position of RM1.64bn and strong operational efficiency which able to weather further economic shocks.

Recommendation: Neutral
Read more details in:

Disclaimer

The report is for internal and private circulation only and shall not be reproduced either in part or otherwise without the prior written consent of Apex Securities Berhad. The opinions and information contained herein are based on available data believed to be reliable. It is not to be construed as an offer, invitation or solicitation to buy or sell the securities covered by this report.

Opinions, estimates and projections in this report constitute the current judgment of the author. They do not necessarily reflect the opinion of Apex Securities Berhad and are subject to change without notice. Apex Securities Berhad has no obligation to update, modify or amend this report or to otherwise notify a reader thereof in the event that any matter stated herein, or any opinion, projection, forecast or estimate set forth herein, changes or subsequently becomes inaccurate.

Apex Securities Berhad does not warrant the accuracy of anything stated herein in any manner whatsoever and no reliance upon such statement by anyone shall give rise to any claim whatsoever against Apex Securities Berhad. Apex Securities Berhad may from time to time have an interest in the company mentioned by this report. This report may not be reproduced, copied or circulated without the prior written approval of Apex Securities Berhad.

Apex TV
Market Mover
Settlement Rates
Currency Buy Rates (RM) Sell Rates (RM)
USD 4.455268 4.488135
EUR 4.716585 4.723137
CNY 0.616518 0.616862
HKD 0.572409 0.576643
SGD 3.318330 3.343262